Craft

NextCure

Stock Price

$1.4

2024-10-29

Market Capitalization

$39.2 M

2024-10-29

Revenue

$22.4 M

FY, 2020

NextCure Summary

Company Summary

Overview
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. The Company offers find-io platform which allows to identify proteins that can be targeted with immunomedicines to repair and maintain anti-tumor immunity,  to assess immune pathways in both primary immune cells and established cell lines from immune lineages.
Type
Public
Status
Active
Founded
2015
HQ
Beltsville, MD, US | view all locations
Website
http://nextcure.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Elaine V. Jones, Director

    • David Kabakoff, Chairman

      • Chau Q. Khuong, Director

        • Steven P. Cobourn

        LocationsView all

        1 location detected

        • Beltsville, MD HQ

          United States

          9000 Virginia Manor Rd #200

        NextCure Financials

        Summary Financials

        Net income (Q3, 2024)
        ($11.5M)
        Cash (Q3, 2024)
        $27.7M
        EBIT (Q3, 2024)
        ($12.5M)
        Enterprise value
        $17.4M

        Footer menu